J&J | SCHULD



Debt Veränderung Datum
AbbVie USD 67.14B 3.94B 2024-12
Abbott USD 13.24B 883M 2025-03
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Baxter International USD 13.13B 191M 2024-12
Bayer EUR 40.7B 465M 2024-12
Becton, Dickinson and Co. USD 19.27B 512M 2025-03
Biogen USD 6.3B 2M 2025-03
Boston Scientific USD 11.31B 563M 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
CONMED USD 892.16M 13.62M 2025-03
Cooper Companies USD 2.54B 43.8M 2025-01
Dexcom USD 2.5B 1000K 2025-03
Edwards Lifesciences USD 597.7M 200K 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Globus Medical USD 443.88M 5M 2024-12
Hologic USD 2.53B 9.4M 2025-03
Indivior 329M 4M 2025-03
Insulet USD 1.39B 6.2M 2024-12
Integra LifeSciences USD 1.8B 3.5M 2024-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 52.25B 15.62B 2025-03
Medtronic USD 26.61B 1.72B 2025-01
Merck USD 37.11B 1.02B 2024-12
Merit Medical Systems USD 730.67M 1.12M 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
Stryker USD 16.78B 3.18B 2025-03
Tandem Diabetes Care USD 354.34M 5.4M 2025-03
Teva Pharmaceutical Industries USD 18.08B 901M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zimmer Biomet Holdings USD 6.2B 246.1M 2024-12
Zoetis USD 6.57B 4M 2024-12



J&J SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.